Meeting
2015 ASCO Annual Meeting
Does metformin use affect transporter, hormone receptor and mTOR pathway target expression in endometrial cancers of women with Type II diabetes mellitus?
Authors
Dario R. Roque
UNC Durham Division of Gynecologic Oncology, Durham, NC
Dario R. Roque , A. Mitch Dizon , Brooke S. Rambally , Siobhan O'Connor , Paola A. Gehrig , Sheri Denslow , Victoria Lin Bae-Jump
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 5594)
DOI
10.1200/jco.2015.33.15_suppl.5594
Abstract #
5594
Poster Bd #
152
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
PI3K/PTEN/Akt/mTOR pathway aberrations and co-incidence of hormone receptors and HER2 in 19,784 diverse solid tumors.
First Author: Sherri Z. Millis
Poster
2014 ASCO Annual Meeting
Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.
First Author: Alexandra Leary
Poster
2013 ASCO Annual Meeting
Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC).
First Author: Dinny Graham
Poster
2013 ASCO Annual Meeting
PTEN loss as a context-dependent determinant of patient outcomes in obese and non-obese endometrioid endometrial cancer patients.
First Author: Zhenlin Ju